Welcome to our dedicated page for Pennant Group SEC filings (Ticker: PNTG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Pennant Group, Inc. (NASDAQ: PNTG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a public Delaware corporation. Pennant is the holding company for independent operating subsidiaries that provide home health, hospice, home care and senior living services across multiple states, and its filings offer detailed insight into this structure and its financial results.
Users can review current reports on Form 8-K in which Pennant describes material events such as acquisitions, credit facility amendments and quarterly earnings releases. For example, the company has filed 8-Ks covering its Amended and Restated Credit Agreement and a First Amendment that added an incremental term loan facility, as well as 8-Ks documenting the completion of acquisitions from UnitedHealth Group and Amedisys related to home health, hospice and palliative care operations.
Amended 8-K filings (8-K/A) on this page include additional information required by SEC rules, such as audited and unaudited abbreviated financial statements of acquired businesses and unaudited pro forma condensed combined financial statements. These documents help readers understand how significant acquisitions may affect Pennant’s financial position and results.
In addition to event-driven filings, investors can access Pennant’s periodic reports on Forms 10-K and 10-Q, which contain full financial statements, segment disclosures for home health and hospice services and senior living services, and discussions of risk factors and non-GAAP metrics. The platform also surfaces filings related to earnings announcements, where Pennant furnishes press releases under Item 2.02 and provides Regulation FD disclosures under Item 7.01.
Stock Titan enhances these documents with AI-powered summaries that explain key sections of lengthy filings, highlight important items such as acquisition terms, credit facility covenants and segment performance, and help readers quickly identify the most relevant information in Pennant’s regulatory history.
Pennant Group (PNTG) executive Kirk Cheney, EVP, General Counsel and Corporate Secretary, reported an insider transaction on 11/11/2025. He acquired 3,800 shares of common stock via an option exercise (Code M) at $15.09 per share.
After the transaction, he beneficially owned 16,920 common shares directly. The exercised employee stock option carried a $15.09 exercise price, first became exercisable on 10/01/2020, and expires on 10/01/2029. Following the exercise, 4,200 derivative securities (stock options) remained beneficially owned.
The Pennant Group (PNTG) entered a material financing amendment. On November 3, 2025, the company added an incremental Term Loan A of $100,000,000 under its Amended and Restated Credit Agreement with Truist Bank and additional lenders.
The new term loans bear the same interest rate and have the same maturity date as the company’s revolving facility. Pennant used the proceeds to refinance a portion of outstanding revolver borrowings and to pay related fees and expenses, effectively shifting debt from revolving to term while keeping pricing and maturity aligned.
The credit facility includes customary representations and covenants, including financial tests based on the Leverage Ratio and the Interest/Rent Coverage Ratio, and limits on additional indebtedness, liens, significant corporate changes, dispositions, and restricted payments. Standard events of default apply, including payment defaults, certain healthcare law violations, change in control, bankruptcy, and other operational covenants; if uncured, lenders may accelerate the debt.
The Pennant Group (PNTG) reported third‑quarter 2025 results with revenue of $229.0 million versus $180.7 million a year ago. Income from operations was $10.2 million compared to $10.8 million, and net income attributable to the company was $6.1 million versus $6.2 million. Diluted EPS was $0.17 versus $0.20.
Home Health and Hospice revenue reached $173.5 million and Senior Living $53.9 million. Segment Adjusted EBITDAR from Operations improved to $44.4 million, led by $29.1 million in Home Health and Hospice and $15.3 million in Senior Living. Year to date, operating cash flow was $27.3 million.
The company expanded through acquisitions in 2025, including part two of Signature Group (contributing $48.8 million revenue and $8.9 million operating income year to date) and additional home health deals. Cash was $2.3 million, long‑term debt was $26.0 million under the revolving credit facility, and total assets were $753.6 million. As of November 3, 2025, 34,593,720 common shares were outstanding. Subsequent to quarter end, Pennant closed a $146.5 million acquisition of home health, hospice, and home care locations and added a $100 million incremental term loan under its credit agreement.
The Pennant Group (PNTG) furnished an update on its third‑quarter performance. On November 5, 2025, the company issued a press release reporting financial results for the quarter ended September 30, 2025, and made the release available as Exhibit 99.1. The company also plans to post an updated investor presentation on its website for upcoming meetings. The information under Items 2.02 and 7.01, including Exhibit 99.1, was furnished and is not deemed filed or incorporated by reference except as specifically stated.
Pennant Group (PNTG)1,900 shares of common stock on 10/15/2025 at $0, indicating an award rather than an open-market purchase. According to the footnote, these shares vest in three annual installments beginning October 15, 2026.
Following this grant, the director beneficially owns 38,350 shares, held directly.
The Pennant Group (PNTG) director Christopher R. Christensen reported an award of 1,900 shares of common stock on October 15, 2025 at $0. The shares vest in three annual installments beginning October 15, 2026.
Following the transaction, he directly owned 140,291 shares and indirectly held 623,347 shares. Indirect holdings include shares held by Hobble Creek Investments, LLC, a 2020 irrevocable trust, his spouse, and shares held by his former spouse as custodian for their minor children.
Pennant Group (PNTG) director reported an equity award. On 10/15/2025, the reporting person acquired 1,900 shares of common stock at a reported price of $0. Following the transaction, the individual beneficially owns 96,799 shares, held directly.
The filing states these shares vest in three annual installments beginning October 15, 2026. This is a routine director equity grant and does not reflect an open‑market purchase.
Pennant Group (PNTG) reported an insider equity transaction by a director. On 10/15/2025, the reporting person acquired 1,900 shares of common stock at $0 per share, bringing total beneficial ownership to 224,664 shares, held directly.
The filing notes these shares vest in three annual installments beginning October 15, 2026.
Pennant Group (PNTG) reported an insider equity transaction by a director on 10/15/2025. The filing shows an acquisition of 1,900 common shares at $0, with a footnote stating these shares vest in three annual installments beginning October 15, 2026. Following the transaction, the director beneficially owns 168,865 shares directly and 2,700 shares indirectly through the Nackel Family Trust, over which the director and spouse share voting and investment power.
Pennant Group (PNTG) reported an insider transaction by a director on October 15, 2025. The director acquired 1,900 shares of common stock at a reported price of $0, bringing beneficial ownership to 31,600 shares, held directly.
The filing notes these shares vest in three annual installments beginning October 15, 2026. This appears to be a routine equity award reflecting standard director compensation practices and does not change control.